Richard A. Larson, MD, is Professor of Medicine in the Section of Hematology/Oncology and Director of the Hematologic Malignancies Clinical Research Program at the University of Chicago. He received his medical degree from the Stanford University School of Medicine in 1977, and completed his postdoctoral training in internal medicine, hematology, and oncology at the University of Chicago. He was a Fellow of the Leukemia Society of America and was granted a Clinical Oncology Career Development Award from the American Cancer Society. He has been a member of the faculty in the Section of Hematology/Oncology and the Comprehensive Cancer Center at the University of Chicago since 1983. He was Director of the Leukemia Clinical Research Program at the University of Chicago from 1983 to 2000, during which time he established the adult allogeneic bone marrow transplant program at the University of Chicago Medical Center in 1986. He is board certified in internal medicine, hematology, and medical oncology, and has served as a member of the Hematology Subspecialty Board of the American Board of Internal Medicine.
Since becoming an ASH member in 1983, Dr. Larson has served the Society as Councillor, Education Program co-chair, Program Committee member, faculty at the Clinical Research Training Institute, and speaker for the Education Program, Highlights of ASH, and the ASH State-of-the-Art Symposium. He has served on the Editorial Board of Blood, the official journal of ASH, and has also been an author for ASH News Daily, the daily newspaper of the ASH annual meeting. From 1997 to 2011, Dr. Larson was the chairman of the Leukemia Committee of the Cancer and Leukemia Group B, where he directed a large portfolio of clinical trials and ancillary laboratory studies in acute and chronic leukemias and myeloma. He is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Larson has published more than 400 papers, reviews, and book chapters on clinical and laboratory studies in human leukemias andhas served on the editorial boards ofthe Journal of Clinical Oncology and Leukemia. He is the Section Editor for Leukemia for UpToDate.
Dr. Larson maintains an active clinical practice at the University of Chicago Medical Center, and his expertise is widely sought for consultations regarding leukemia and the myelodysplastic syndromes. He participates actively in the training of 22 fellows in hematology/oncology within the Department of Medicine. His current research interests include clinical trials in hematologic malignancies and stem-cell transplantation, experimental therapeutics, the determinants of response to therapy in leukemia and myelodysplastic syndromes, and the etiology of therapy-related leukemias.
back to top